Lobbying client

MONOAMINE OXIDASE DEFICIENCY FOUNDATION

Medical Research and outreach to find treatments and cures for MAO Deficiency

Filings
9
Filed by
1
Reported in-house
—
Reported by firms
$151,500

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2022 to 2025

Filings

9 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination
3rd Quarter 2025
ELLIS & COMPANY, LLC $21,500 reported
2nd Quarter - Report
2nd Quarter 2025
ELLIS & COMPANY, LLC $21,500 reported
1st Quarter - Report
1st Quarter 2025
ELLIS & COMPANY, LLC $21,500 reported
4th Quarter - Report
4th Quarter 2024
ELLIS & COMPANY, LLC $21,500 reported
3rd Quarter - Amendment
3rd Quarter 2024
ELLIS & COMPANY, LLC $21,500 reported
2nd Quarter - Report
2nd Quarter 2024
ELLIS & COMPANY, LLC $21,500 reported
2nd Quarter - Report
2nd Quarter 2022
ELLIS & COMPANY, LLC $17,500 reported
1st Quarter - Report
1st Quarter 2022
ELLIS & COMPANY, LLC $5,000 reported
Registration
1st Quarter 2022
ELLIS & COMPANY, LLC — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
ELLIS & COMPANY, LLC 8 $151,500

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 3
Medical/Disease Research/Clinical Labs MED 2
Veterans VET 2

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.